Global EditionASIA 中文雙語Fran?ais
    Opinion
    Home / Opinion / Chinese Perspectives

    Tariffs are not the cure for the US Fentanyl crisis

    By Alice Wu | chinadaily.com.cn | Updated: 2025-03-12 11:55
    Share
    Share - WeChat
    Plastic bags of Fentanyl are displayed on a table at the US Customs and Border Protection area at the International Mail Facility at O'Hare International Airport in Chicago, Illinois, US, November 29, 2017. [Photo/Agencies]

    Additional US tariffs on China went into effect on March 4. Under what pretext? Fentanyl. The US has cited illicit drugs “pouring into our country” as the primary reason and blamed China for not doing enough.

    The US may see tariffs as the cure. They are not. The only significant effect was a heavier burden on American consumers. The cure must come from within.

    In recent years, fentanyl abuse has become a severe crisis in the US With less than 5% of the world's population, the country consumes over 80% of the global opioid supply. Statistics from the US Centers for Disease Control and Prevention show that synthetic opioids—primarily illicitly manufactured fentanyl—were involved in 75,000 overdose deaths in 2023, accounting for nearly 70% of the total. Over 150 Americans die daily from overdoses linked to synthetic opioids like fentanyl, making it the leading cause of death for Americans aged 18 to 45.

    A key driver of this crisis is easy access: over-prescription, lax regulation, and insufficient public awareness campaigns. As a Los Angeles County sheriff noted, “Getting fentanyl is as easy as ordering pizza.”

    Where is the US government in all this? Instead of addressing root causes, politicians have sought foreign scapegoats—and once again, China is the target. They claim China bears responsibility for the unrelenting crisis and the loss of American lives to illicit drugs.

    Anyone familiar with China's modern history knows the trauma inflicted by the Opium Wars. This legacy fuels China's deep antipathy toward narcotics and its zero-tolerance policy. The Chinese people empathize with Americans grappling with this crisis.

    In fact, China has one of the world’s strictest counter-narcotics policies and enforces it rigorously. In 2019, China became the first nation to classify all fentanyl-related substances as controlled drugs. According to the 2023 China Drug Situation Report, registered drug users in China fell to 896,000 by late 2023—a 20.3% annual decrease, representing just 0.064% of the population.

    China recently released a white paper titled Controlling Fentanyl-Related Substances: China’s Contribution, detailing efforts to regulate fentanyl medications, prevent abuse, crack down on illegal activities, and support global drug control.

    The US has received substantial Chinese cooperation in combating fentanyl, including joint efforts in drug scheduling, intelligence sharing, case collaboration, online ad removal, drug-testing technology exchanges, and multilateral engagement. In January 2024, the two nations established a bilateral Counternarcotics Working Group. In July 2024, a Chinese interagency delegation attended its first senior-level meeting in the US. A press release of the US State Department acknowledged that the working group “complements ongoing efforts...to counter the fentanyl scourge.”

    The US State Department’s 2024 International Narcotics Control Strategy Report concedes that “almost no fentanyl or analogues have entered the US directly from China since 2019,” when China imposed class-wide controls. US CDC data indicates overdose deaths dropped approximately 14% from June 2023 to June 2024—the sharpest decline in history—a result partly attributable to China's actions.

    Yet the US persistently overlooks China's contributions. Using fentanyl as justification, it hiked tariffs on China twice in a single month. This strategy of repaying goodwill with hostility has proven irresponsible and self-defeating.

    Scapegoating solves nothing. As Hillbilly Elegy observes, “We tend to glorify the good and ignore the bad in ourselves.” If the US truly wants to end the fentanyl crisis, it must confront its domestic failures and act swiftly. Further delays or distractions will only perpetuate negligence and more preventable deaths.

    The author is a Beijing-based independent observer of international affairs.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    人妻少妇久久中文字幕一区二区| 最新中文字幕AV无码不卡| 亚洲精品无码久久千人斩| 亚洲 欧美 中文 在线 视频| 无码一区二区三区在线观看| 久久久久综合中文字幕| 中文在线最新版天堂bt| 精品国产v无码大片在线观看| 国产精品 中文字幕 亚洲 欧美 | 性无码专区一色吊丝中文字幕| 中文字幕人妻无码一夲道| 无码AV中文字幕久久专区| 国产99久久九九精品无码| 亚洲午夜无码久久久久| 久久精品中文字幕一区| 精品人妻中文av一区二区三区| 亚洲成?v人片天堂网无码| 国产成人无码综合亚洲日韩 | 久久精品无码午夜福利理论片 | 亚洲国产精品无码久久久不卡| 中文字幕视频在线| 日本成人中文字幕| 亚洲欧美日韩中文在线制服| 久本草在线中文字幕亚洲欧美| 中文无码一区二区不卡αv| 日韩无码系列综合区| 国产精品成人无码久久久久久| 人妻丰满AV无码久久不卡| 日韩精品无码AV成人观看| 无码日韩精品一区二区三区免费| 亚洲AV成人无码久久精品老人| 亚洲A∨无码一区二区三区| 亚洲AV无码成人网站久久精品大| 亚洲中文字幕无码久久精品1 | 无码成A毛片免费| 亚洲av无码专区国产乱码在线观看| 亚洲中文无韩国r级电影| 人妻少妇无码精品视频区 | 曰韩人妻无码一区二区三区综合部 | 丰满少妇人妻无码| 国产亚洲精品a在线无码|